Kestra Advisory Services’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$711K Buy
7,858
+444
+6% +$40.7K ﹤0.01% 1967
2025
Q4
$667K Buy
7,414
+992
+15% +$94.1K ﹤0.01% 1943
2025
Q3
$633K Sell
6,422
-682
-10% -$67.6K ﹤0.01% 1899
2025
Q2
$648K Buy
7,104
+310
+5% +$30K ﹤0.01% 1794
2025
Q1
$769K Sell
6,794
-515
-7% -$55.1K ﹤0.01% 1550
2024
Q4
$772K Sell
7,309
-981
-12% -$105K ﹤0.01% 1564
2024
Q3
$895K Sell
8,290
-194
-2% -$21.2K ﹤0.01% 1392
2024
Q2
$921K Buy
8,484
+2,165
+34% +$255K 0.01% 1375
2024
Q1
$834K Buy
6,319
+274
+5% +$34.2K 0.01% 1355
2023
Q4
$736K Sell
6,045
-143
-2% -$16K 0.01% 1283
2023
Q3
$694K Buy
6,188
+820
+15% +$104K 0.01% 1185
2023
Q2
$782K Buy
5,368
+43
+0.8% +$5.84K 0.01% 1094
2023
Q1
$688K Sell
5,325
-5,385
-50% -$676K 0.01% 1124
2022
Q4
$1.37M Buy
10,710
+2,407
+29% +$279K 0.01% 910
2022
Q3
$868K Sell
8,303
-2,577
-24% -$283K 0.01% 1039
2022
Q2
$1.14M Buy
10,880
+1,956
+22% +$232K 0.01% 912
2022
Q1
$1.14M Buy
8,924
+1,357
+18% +$164K 0.01% 897
2021
Q4
$933K Sell
7,567
-977
-11% -$128K 0.01% 1020
2021
Q3
$1.21M Buy
8,544
+878
+11% +$129K 0.01% 908
2021
Q2
$1.2M Buy
7,666
+151
+2% +$24.5K 0.01% 853
2021
Q1
$1.17M Buy
7,515
+1,997
+36% +$309K 0.01% 805
2020
Q4
$816K Buy
5,518
+5,466
+10,512% +$772K 0.01% 959
2020
Q3
$449K Buy
+52
New +$6.79K 0.01% 938

Other funds holding ZBH

Kestra Advisory Services's ZBH Position: Q1 2026 in Review

Kestra Advisory Services increased its Zimmer Biomet (ZBH) stake by 6% in Q1 2026, buying an estimated $40.7K and bringing the position to 7,858 shares worth $711K. The position accounts for ﹤0.01% of the portfolio, ranked #1967.

Kestra Advisory Services first reported a position in ZBH in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.37M in Q4 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Kestra Advisory Services held 7,858 shares of Zimmer Biomet worth $711K as of Q1 2026.
  • Kestra Advisory Services bought 444 Zimmer Biomet shares in Q1 2026, an estimated $40.7K.
  • Zimmer Biomet made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #1967 holding.
  • Kestra Advisory Services first reported a position in Zimmer Biomet in Q3 2020 and has held it in 23 quarters since.
  • Kestra Advisory Services's Zimmer Biomet position peaked at $1.37M in Q4 2022.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.